12 Maggio 2025
50 Minutes on MM – MRD: THE EVOLUTION OF ITS CLINICAL SIGNIFICANCE
Chaired by Roberto Mina, with Bruno Paiva and Elena Zamagni
20 Maggio 2025
50 Minutes on MM – SEQUENCING AND RESISTANCE MECHANISMS IN NOVEL IMMUNOTHERAPIES
Chaired by Roberto Mina, with Niels Van De Donk and Niccolò Bolli
27 Maggio 2025
50 Minutes on MM – ARTIFICIAL INTELLIGENCE IN HEMATOLOGY
Chaired by Roberto Mina, with Adrian Mosquera Orgueira and Matteo Giovanni Della Porta
3 Ottobre 2024
50 Minutes on MM – HOW TO MANAGE SMM IN 2024 – FROM RISK STRATIFICATION TO EARLY INTERVENTION
Special Lectures on management of patients with smouldering myeloma (M. V. Mateos Manteca)
How to manage SMM in 2024 – from risk stratification to early intervention (R. Mina, M.V. Mateos Manteca)
10 Ottobre 2024
50 Minutes on MM – NDMM UNMET MEDICAL NEEDS, FUNCTIONAL AND CYTHOGENETIC HIGH RISK POPULATION
Special Lectures on treatment of the newly diagnosed patient with multiple myeloma (S. Usmani)
NDMM unmet medical needs, functional and cythogenetic high risk population (R. Mina e S. Usmani)
17 Ottobre 2024
50 Minutes on MM – AL AMYLOIDOSIS: AN HOLISTIC APPROACH TO THE PATHOLOGY
Special Lectures on AL Amyloidosis (P. Milani)
AL amyloidosis: an holistic approach to the pathology (R. Mina e P. Milani)
24 Ottobre 2024
50 Minutes on MM – HYPEREOSINOPHILIC SYNDROME (HES)
Special Lectures on hypereosinophilic syndrome (F. E. Roufosse)
Discussion on HES (G. G. Loscocco and F. E. Roufosse)
2 Novembre 2023
50 Minutes on MM – HOW TO MANAGE ADVERSE EVENTS IN PATIENTS RECEIVING BCMA TARGETING AGENTS
Special Lectures on the BCMA – targeting drugs and their toxicity profile (E. Terpos)
How to manage BCMA-targeting drugs and associated adverse events: from trials to clinical practice (R. Mina, E. Terpos)
16 Novembre 2023
50 Minutes on MM –
TREATMENT SEQUENCING IN THE ERA OF IMMUNOTHERAPY: BCMA AND BEYOND
Special Lectures on sequencing strategies in the era of immunotherapy for relapsed myeloma patients (S. Lonial)
Practical consideration to tailor treatment with new immunotherapeutic agents (S. Lonial, R. Mina)
23 Novembre 2023
50 Minutes on MM –
FROM SINGLE-CELL TO SINGLE PATIENT: NOVEL INSIGHTS INTO MECHANISMS OF RELAPSE FROM NOVEL IMMUNOTHERAPIES IN MULTIPLE MYELOMA
Special Lectures on personalised prediction of progression in asymptomatic patients with monoclonal gammopathies (E. P. Neri)
Practical consideration to tailor treatment with new immunotherapeutic agents (S. Lonial, R. Mina)
17 Ottobre 2022
50 MINUTE ON MM – Liquid Biopsy
24 Ottobre 2022
50 MINUTE ON MM – Extramedullary Disease
7 Novembre 2022
50 MINUTE ON MM – BCMA as target